碳酸无水素酶抑制使第三组神经母细胞瘤对放射治疗产生敏感性
Cory M Richman1, Alexandra Rasnitsyn1, Borja L Holgado1
1SickKids Foundation, Toronto, Ontario, Canada.
Cancer research
|July 25, 2025
概括
第三组髓母细胞瘤是攻击性的. 用乙醇胺针对碳酸 anhydrase 4 (CA4) 可能改善放射治疗的疗效,并减少儿科患者的复发.
科学领域:
- 儿科瘤学 儿科瘤学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 第三组髓母细胞瘤是最具攻击性的亚型,经常出现转移.
- 目前的治疗方法对复发性脑髓母细胞瘤缺乏生存益处.
- 了解抵抗机制对于改善结果至关重要.
研究的目的:
- 确定3组脑髓母细胞瘤的可操作目标和生物标志物.
- 降低复发风险,改善新诊断患者的生存率.
- 研究放射电阻的机制.
主要方法:
- 使用了临床相关的小鼠模型,研究了第三组脑髓母细胞瘤.
- 采用了CT指导的分离放射治疗.
- 复发性瘤的基因表达特征与以前未经治疗的瘤的基因表达特征的比较.
- 研究了碳酸无水酶4 (CA4) 的表达和功能.
主要成果:
- 放射治疗诱导的耐辐射亚种群导致复发.
- 发现了放射电阻和不良预后的预后基因特征.
- 在复发瘤中CA4表达升高.
- CA4调制影响了放射疗法耐药性;乙醇胺显示出作为放射敏感剂的潜力.
结论:
- 在3组脑髓母细胞瘤中,CA4是潜在的治疗点.
- 乙胺可以提高放射治疗的疗效,减少复发.
- 研究结果表明,对于新诊断的儿科骨髓母细胞瘤,改善了治疗策略.
相关概念视频
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
322
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
322
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
262
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
262